September push for senior CBD use and talk of looser US marijuana rules have revived investor interest, from shop profits to ...

A new study has found that, contrary to expectations, pre-treatment with cannabidiol, or CBD, exacerbated the acute memory ...

New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cannabidiol Global Market Report 2023" - https://www.reportlinker ...

New York, Dec. 11, 2023 (GLOBE NEWSWIRE) -- According to the market.us, the global Cannabidiol Market Size was valued at USD 7.6 billion in 2023 and is anticipated to reach approximately USD 36.6 ...

Harmony also touts late-stage asset EPX-100 (clemizole hydrochloride), which the biotech is running through a pair of phase 3 trials in Dravet syndrome and Lennox-Gastaut Syndrome— both rare forms of ...

Cannabidiol (Epidiolex) may alter blood levels of several commonly used antiepileptic drugs in adults and children, according to an open-label study published in Epilepsia. Cannabidiol showed ...

Cannabidiol may halve the severity of chronic anxiety symptoms and impairment in young people, an Orygen pilot study has shown Cannabidiol may be effective in halving the severity of symptoms and ...

Cannabidiol, a non-intoxicating derivative from cannabis, has been shown to reduce seizures and autism-like behaviors in a mouse model of a genetic disorder, Dravet syndrome. Children with this ...

CBD is everywhere, just Google it. Cannabidiol, the popular hemp plant derivative marketed as a cure-all for just about any condition, has only been approved by federal regulators to treat some rare ...

Please provide your email address to receive an email when new articles are posted on . Survey responses reflected positive language and communication outcomes after cannabidiol use. Further ...

A new study involving 11 epilepsy centers across the United States shows that a drug made from a medical marijuana derivative can reduce seizures in children and young adults with epilepsy who don't ...

The appraisal committee considered evidence submitted by GW Pharma, a review of this submission by the evidence review group (ERG) and the technical report developed through engagement with ...